Acumen Pharmaceuticals, Inc.
ABOS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$26,451 | -$40,950 | -$28,796 | -$37,154 |
| Dep. & Amort. | $0 | $47 | $45 | $44 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $2,498 | $2,474 | $0 |
| Change in WC | -$7,026 | $6,275 | -$7,362 | $8,221 |
| Other Non-Cash | $2,988 | $298 | -$482 | $1,674 |
| Operating Cash Flow | -$30,489 | -$31,832 | -$34,121 | -$27,215 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$9 | -$79 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$3,008 | -$35,048 | -$15,100 |
| Inv. Sales/Matur. | $40,511 | $41,500 | $63,816 | $44,763 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $40,511 | $38,483 | $28,689 | $29,663 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | -$739 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | -$73 | -$9 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $37 | $739 |
| Financing Cash Flow | $0 | $0 | -$36 | -$9 |
| Forex Effect | $0 | $0 | $0 | $4 |
| Net Chg. in Cash | $10,022 | $6,651 | -$5,468 | $2,443 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $36,810 | $30,391 | $35,859 | $33,184 |
| End Cash | $46,832 | $37,042 | $30,391 | $35,627 |
| Free Cash Flow | -$30,489 | -$31,841 | -$34,200 | -$27,215 |